338 related articles for article (PubMed ID: 21632209)
1. Cellular microRNAs (miRNAs) and Sjögren's syndrome: candidate regulators of autoimmune response and autoantigen expression.
Kapsogeorgou EK; Gourzi VC; Manoussakis MN; Moutsopoulos HM; Tzioufas AG
J Autoimmun; 2011 Sep; 37(2):129-35. PubMed ID: 21632209
[TBL] [Abstract][Full Text] [Related]
2. Study of microRNAs (miRNAs) that are predicted to target the autoantigens Ro/SSA and La/SSB in primary Sjögren's Syndrome.
Gourzi VC; Kapsogeorgou EK; Kyriakidis NC; Tzioufas AG
Clin Exp Immunol; 2015 Oct; 182(1):14-22. PubMed ID: 26201309
[TBL] [Abstract][Full Text] [Related]
3. Endoplasmic reticulum stress causes autophagy and apoptosis leading to cellular redistribution of the autoantigens Ro/Sjögren's syndrome-related antigen A (SSA) and La/SSB in salivary gland epithelial cells.
Katsiougiannis S; Tenta R; Skopouli FN
Clin Exp Immunol; 2015 Aug; 181(2):244-52. PubMed ID: 25845745
[TBL] [Abstract][Full Text] [Related]
4. A comprehensive review of autoantibodies in primary Sjögren's syndrome: clinical phenotypes and regulatory mechanisms.
Kyriakidis NC; Kapsogeorgou EK; Tzioufas AG
J Autoimmun; 2014 Jun; 51():67-74. PubMed ID: 24333103
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of Ro/SSA 60 kDa and La/SSB, but not Ro/SSA 52 kDa, mRNA and protein in minor salivary glands from patients with primary Sjögren's syndrome.
Barcellos KS; Nonogaki S; Enokihara MM; Teixeira MS; Andrade LE
J Rheumatol; 2007 Jun; 34(6):1283-92. PubMed ID: 17552056
[TBL] [Abstract][Full Text] [Related]
6. Fibulin-6 expression and anoikis in human salivary gland epithelial cells: implications in Sjogren's syndrome.
Sisto M; D'Amore M; Lofrumento DD; Scagliusi P; D'Amore S; Mitolo V; Lisi S
Int Immunol; 2009 Mar; 21(3):303-11. PubMed ID: 19190085
[TBL] [Abstract][Full Text] [Related]
7. Y RNA derived small RNAs in Sjögren's syndrome: Candidate biomarkers?
Kabeerdoss J; Sandhya P; Danda D
Int J Rheum Dis; 2017 Nov; 20(11):1763-1766. PubMed ID: 29152879
[TBL] [Abstract][Full Text] [Related]
8. Immunization with 60 kD Ro peptide produces different stages of preclinical autoimmunity in a Sjögren's syndrome model among multiple strains of inbred mice.
Kurien BT; Dsouza A; Igoe A; Lee YJ; Maier-Moore JS; Gordon T; Jackson M; Scofield RH
Clin Exp Immunol; 2013 Jul; 173(1):67-75. PubMed ID: 23607771
[TBL] [Abstract][Full Text] [Related]
9. Are the Ro RNP-associated Y RNAs concealing microRNAs? Y RNA-derived miRNAs may be involved in autoimmunity.
Verhagen AP; Pruijn GJ
Bioessays; 2011 Sep; 33(9):674-82. PubMed ID: 21735459
[TBL] [Abstract][Full Text] [Related]
10. LAMP3 induces apoptosis and autoantigen release in Sjögren's syndrome patients.
Tanaka T; Warner BM; Odani T; Ji Y; Mo YQ; Nakamura H; Jang SI; Yin H; Michael DG; Hirata N; Suizu F; Ishigaki S; Oliveira FR; Motta ACF; Ribeiro-Silva A; Rocha EM; Atsumi T; Noguchi M; Chiorini JA
Sci Rep; 2020 Sep; 10(1):15169. PubMed ID: 32939030
[TBL] [Abstract][Full Text] [Related]
11. Autoantigen-targeting microRNAs in Sjögren's syndrome.
Yang Y; Peng L; Ma W; Yi F; Zhang Z; Chen H; Guo Y; Wang L; Zhao LD; Zheng W; Li J; Zhang F; Du Q
Clin Rheumatol; 2016 Apr; 35(4):911-7. PubMed ID: 26888739
[TBL] [Abstract][Full Text] [Related]
12. TNF blocker drugs modulate human TNF-α-converting enzyme pro-domain shedding induced by autoantibodies.
Sisto M; Lisi S; Lofrumento DD; Caprio S; Mitolo V; D'Amore M
Immunobiology; 2010 Nov; 215(11):874-83. PubMed ID: 20061048
[TBL] [Abstract][Full Text] [Related]
13. Sjögren's syndrome: autoantibodies to cellular antigens. Clinical and molecular aspects.
Mavragani CP; Tzioufas AG; Moutsopoulos HM
Int Arch Allergy Immunol; 2000 Sep; 123(1):46-57. PubMed ID: 11014971
[TBL] [Abstract][Full Text] [Related]
14. Detection of anti-Ro/SSA and anti-La/SSB autoantibody-producing cells in salivary glands from patients with Sjögren's syndrome.
Tengnér P; Halse AK; Haga HJ; Jonsson R; Wahren-Herlenius M
Arthritis Rheum; 1998 Dec; 41(12):2238-48. PubMed ID: 9870881
[TBL] [Abstract][Full Text] [Related]
15. Subcellular redistribution and surface exposure of the Ro52, Ro60 and La48 autoantigens during apoptosis in human ductal epithelial cells: a possible mechanism in the pathogenesis of Sjögren's syndrome.
Ohlsson M; Jonsson R; Brokstad KA
Scand J Immunol; 2002 Nov; 56(5):456-69. PubMed ID: 12410795
[TBL] [Abstract][Full Text] [Related]
16. Matriptase deletion initiates a Sjögren's syndrome-like disease in mice.
Yin H; Kosa P; Liu X; Swaim WD; Lai Z; Cabrera-Perez J; Di Pasquale G; Ambudkar IS; Bugge TH; Chiorini JA
PLoS One; 2014; 9(2):e82852. PubMed ID: 24551030
[TBL] [Abstract][Full Text] [Related]
17. SS-56, a novel cellular target of autoantibody responses in Sjögren syndrome and systemic lupus erythematosus.
Billaut-Mulot O; Cocude C; Kolesnitchenko V; Truong MJ; Chan EK; Hachula E; de la Tribonnière X; Capron A; Bahr GM
J Clin Invest; 2001 Sep; 108(6):861-9. PubMed ID: 11560955
[TBL] [Abstract][Full Text] [Related]
18. Toll-like receptor 3 stimulation promotes Ro52/TRIM21 synthesis and nuclear redistribution in salivary gland epithelial cells, partially via type I interferon pathway.
Kyriakidis NC; Kapsogeorgou EK; Gourzi VC; Konsta OD; Baltatzis GE; Tzioufas AG
Clin Exp Immunol; 2014 Dec; 178(3):548-60. PubMed ID: 25098814
[TBL] [Abstract][Full Text] [Related]
19. Intracellular trafficking and surface expression of SS-A (Ro), SS-B (La), poly(ADP-ribose) polymerase and alpha-fodrin autoantigens during apoptosis in human salivary gland cells induced by tumour necrosis factor-alpha.
McArthur C; Wang Y; Veno P; Zhang J; Fiorella R
Arch Oral Biol; 2002 Jun; 47(6):443-8. PubMed ID: 12102760
[TBL] [Abstract][Full Text] [Related]
20. Passive transfer of antibodies to the linear epitope 60 kD Ro 273-289 induces features of Sjögren's syndrome in naive mice.
Maier-Moore JS; Kurien BT; D'Souza A; Bockus L; Asfa S; Dorri Y; Hubbell S; Yeliosof O; Obeso D; Schoeb TR; Jonsson R; Scofield RH
Clin Exp Immunol; 2015 Apr; 180(1):19-27. PubMed ID: 25370295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
